Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma
Thomas Jefferson University
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc